Skip to main content
Top
Published in: Netherlands Heart Journal 11/2015

Open Access 01-11-2015 | Original Article - Design Study Article

Trends in incidence of infective endocarditis at the Medical Center of Alkmaar

Authors: M.M.G. Krul, A.B.A. Vonk, J.H. Cornel

Published in: Netherlands Heart Journal | Issue 11/2015

Login to get access

Abstract

Introduction

Infective endocarditis (IE) is a life-threatening illness with a high morbidity and mortality, and with a rise in incidence in patients with prosthetic valves and cardiac devices. Recently the Dutch guidelines of IE prophylaxis have been revised, limiting IE prophylaxis to the highest-risk population. The aim of the present study was to investigate the incidence of IE and its trend between 2008–2013 in a regional hospital in the Netherlands.

Methods

This is an observational descriptive study of all patients who were admitted with IE to the Medical Center of Alkmaar (MCA) from 1 January 2008 to 31 December 2013.

Results

A total of 89 patients with IE, including 7 patients (7.9 %) with a cardiac device IE (CDIE), were identified. In 2008 there were 8 patients with IE, this increased to 26 patients in 2013. Patients with a prosthetic valve IE increased from 25 % in 2008 to 34.6 % in 2013. This increase was not seen in patients with CDIE.

Conclusion

In the MCA we have observed an increase in patients with IE since 2010. This increase was in part attributable to prosthetic valve IE. A larger observational study is needed to investigate the increase of IE in the Netherlands.
Literature
1.
go back to reference Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.CrossRefPubMed Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.CrossRefPubMed
2.
go back to reference Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199–202.CrossRefPubMed Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199–202.CrossRefPubMed
3.
5.
go back to reference Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedCentralCrossRefPubMed Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedCentralCrossRefPubMed
6.
go back to reference Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.CrossRefPubMed Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.CrossRefPubMed
7.
go back to reference van der Meer JT, Thompson J, Valkenburg HA, et al. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152:1863–8.CrossRefPubMed van der Meer JT, Thompson J, Valkenburg HA, et al. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152:1863–8.CrossRefPubMed
8.
go back to reference Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–6.CrossRefPubMed Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–6.CrossRefPubMed
9.
go back to reference Stofmeel MA, Kelder JC, van Hemel NM, et al. [Implanted pacemakers in the Netherlands, 1984–1997; number, types and patient characteristics]. Ned Tijdschr Geneeskd. 2001;145:1254–8.PubMed Stofmeel MA, Kelder JC, van Hemel NM, et al. [Implanted pacemakers in the Netherlands, 1984–1997; number, types and patient characteristics]. Ned Tijdschr Geneeskd. 2001;145:1254–8.PubMed
10.
go back to reference Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRefPubMed Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRefPubMed
11.
go back to reference Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.CrossRefPubMed Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.CrossRefPubMed
12.
go back to reference Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–4.CrossRefPubMed Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–4.CrossRefPubMed
13.
go back to reference Knoll B, Baddour LM, Wilson WR. In: Mandell GL, Bennett JE, Dollin R, editors. Mandell, douglas and benett’s principles and practice of infectious diseases. 2010. pp 1113–26. Knoll B, Baddour LM, Wilson WR. In: Mandell GL, Bennett JE, Dollin R, editors. Mandell, douglas and benett’s principles and practice of infectious diseases. 2010. pp 1113–26.
14.
go back to reference Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.CrossRefPubMed Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.CrossRefPubMed
15.
go back to reference Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138:739–60.CrossRefPubMed Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138:739–60.CrossRefPubMed
17.
go back to reference Alagna L, Park LP, Nicholson BP, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis—Prospective Cohort Study. Clin Microbiol Infect. 2014;20:566–75.CrossRefPubMed Alagna L, Park LP, Nicholson BP, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis—Prospective Cohort Study. Clin Microbiol Infect. 2014;20:566–75.CrossRefPubMed
18.
go back to reference Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392.PubMedCentralCrossRefPubMed Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392.PubMedCentralCrossRefPubMed
19.
20.
go back to reference Rogers AM, Schiller NB. Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008;21:775.CrossRefPubMed Rogers AM, Schiller NB. Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008;21:775.CrossRefPubMed
22.
go back to reference DeSimone DC, Tleyjey IM, Correa DD. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126:60–4.PubMedCentralCrossRefPubMed DeSimone DC, Tleyjey IM, Correa DD. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126:60–4.PubMedCentralCrossRefPubMed
23.
go back to reference Bekdeli B, Wang Y, Kim N. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217–26.CrossRef Bekdeli B, Wang Y, Kim N. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217–26.CrossRef
24.
go back to reference Dayer MJ, Jones S, Prendergast B. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2014. doi:10.1016/S0140-6736(14)62007-9. (pii: S0140-6736(14)62007-9). Dayer MJ, Jones S, Prendergast B. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2014. doi:10.1016/S0140-6736(14)62007-9. (pii: S0140-6736(14)62007-9).
25.
go back to reference Duval X, Hoen B. Prophylaxis for infective endocarditis: let’s end the debate. Lancet. 2014. doi:10.1016/S0140-6736(14)62121-8. (pii: S0140-6736(14)62121-8). Duval X, Hoen B. Prophylaxis for infective endocarditis: let’s end the debate. Lancet. 2014. doi:10.1016/S0140-6736(14)62121-8. (pii: S0140-6736(14)62121-8).
27.
go back to reference Mansur AJ, Dal Bo CM, Fukushima JT, et al. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J. 2001;141:78–86.CrossRefPubMed Mansur AJ, Dal Bo CM, Fukushima JT, et al. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J. 2001;141:78–86.CrossRefPubMed
28.
go back to reference Renzulli A, Carozza A, Romano G, et al. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg. 2001;72:39–43.CrossRefPubMed Renzulli A, Carozza A, Romano G, et al. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg. 2001;72:39–43.CrossRefPubMed
Metadata
Title
Trends in incidence of infective endocarditis at the Medical Center of Alkmaar
Authors
M.M.G. Krul
A.B.A. Vonk
J.H. Cornel
Publication date
01-11-2015
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 11/2015
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-015-0743-0

Other articles of this Issue 11/2015

Netherlands Heart Journal 11/2015 Go to the issue